XGENE
XGene focuses on developing ultra-small, long-distance and high-precision automotive binocular technology that can be used on self-driving cars, drones, robotics and other smart devices. The automatic collision avoidance binocular system developed by the company is being integrated by Chinese logistics firms, drones and self-driving cars, XGene said without giving out details.
XGENE
Industry:
Developer Tools Electronics
Founded:
2011-01-01
Address:
Taiwan, Jiangsu, China
Country:
China
Total Employee:
1+
Status:
Active
Total Funding:
10 M USD
Current Employees Featured
Founder
Investors List
CAIF
CAIF investment in Series A - XGene
The Hina Group
The Hina Group investment in Series A - XGene
More informations about "XGene"
About Us - Xgene Pharmaceutical Group.
Established in 2015, Xgene Pharmaceutical Inc. engineers high-impact medications for unmet underserved needs in neurological conditions. Xgene’s proprietary linker technology generates …See details»
Xgene Pharmaceutical - Crunchbase Company Profile …
Xgene Pharmaceutical is a late-clinical stage, venture-backed international company that uses proprietary linker technology to develop novel, multimodal conjugated molecules for the treatment of neurological disorders. Current …See details»
Leadership Team - Xgene Pharmaceutical Group.
Leadership Team Gene Hsu Ph.D. DABT CEO & Founder Gene Hsu is the chairman and CEO of Xgene Pharmaceutical Inc. Prior to Xgene Pharmaceutical Inc., Dr. Hsu was the Senior Vice President of HEC Pharm Group, Chief …See details»
Xgene Pharmaceutical Company Profile 2024: …
Xgene Pharmaceutical was founded in 2015. Where is Xgene Pharmaceutical headquartered? Xgene Pharmaceutical is headquartered in Taipei, Taiwan. What industry is Xgene Pharmaceutical in? Xgene Pharmaceutical’s primary …See details»
Xgene - LinkedIn
Xgene is currently in the role of internal supplier to Hof Therapeutics Inc. | Xgene Corporation has focused on enabling core technologies to advance human ability to have our biology work for …See details»
Xgene Pharmaceutical - Products, Competitors, Financials, …
Key Acute Pain Companies: Pharmbio Korea Co., Ltd., Xgene Pharmaceutical, Mylan Specialty, Allay Therapeutics, Inc., Johnson & Johnson, RDC Clinical Pty Ltd, Halia Therapeutics, Inc., …See details»
Xgene Pharmaceutical - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised ... obfuscated. obfuscated. CITIC Securities, …See details»
Xgene Pharma of Shanghai Closes $20 Million B Round for Pain …
Oct 25, 2018 Xgene Pharma, a Shanghai start-up, raised $20 million in series B financing round led by Ping An Ventures. Xgene's lead product, a combination of naproxen and pregabalin …See details»
News - Xgene Pharmaceutical Group.
Xgene Pharmaceutical Announces Positive Topline Results from Phase 2b Trial of XG005 Tablet for Treating the Symptoms of Osteoarthritis of the Knee. Aug 08,2024 ... Today’s data are a …See details»
Series C - Xgene Pharmaceutical - 2021-11-05 - Crunchbase
Nov 5, 2021 Organization Name . Xgene Pharmaceutical . Announced Date Nov 5, 2021; Funding Type Series C; Funding Stage Late Stage Venture; Money Raised . $40M. Lead …See details»
Xgene (Biotechnology) Company Profile 2024: Valuation, Funding ...
Xgene (Biotechnology) General Information Description. Developer of biomedical products intended to provide medical and cosmetic advances ready for production use. The company's …See details»
Ping An Ventures leads $20m round for China's Xgene
Nov 10, 2023 Xgene Pharmaceutical, a Chinese drug maker, has raised $20 million in a Series B round of funding led by Ping An Ventures with participation from Zhongtai Investment – a …See details»
Rescuing Data Integrity: How Xgene Empowers Pharmaceutical
May 19, 2023 Through targeted training sessions, they enhance employees' understanding of audit trail requirements and promote a culture of compliance within the organization. …See details»
Our Science - Xgene Pharmaceutical Group.
Xgene utilizes a novel proprietary chemical conjugation method to link different moieties with complementary mechanisms of action. This technology, unlike taking the two drugs together or …See details»
From Warning to Winning: Xgene's Remediation Magic for FDA
May 19, 2023 Xgene also facilitates effective communication with the FDA, providing guidance on how to respond to agency inquiries, address additional requests for information, and …See details»
XGene - Crunchbase Company Profile & Funding
Sep 28, 2016 XGene focuses on developing ultra-small, long-distance and high-precision automotive binocular technology that can be used on self-driving cars, drones, robotics and …See details»
A lifelong duty: how Xist maintains the inactive X chromosome
Aug 23, 2023 A) i) The E-repeat binding proteins PTBP1, MATR3, TDP-43 and CELF1 bind to the E repeat in wildtype Xist, a 1.4kb region that contains a large number of sequence motifs …See details»
Board of Directors - Xgene Pharmaceutical Group.
Board of Directors Gene HsuPh.D.DABTChairman Gene Hsu is the chairman and CEO of Xgene Pharmaceutical Inc. Prior to Xgene Pharmaceutical Inc., Dr. Hsu was the Senior Vice …See details»
Gene Structure and Organization - Rowen - Wiley Online Library
Sep 23, 2005 Introduction. Deoxyribonucleic acid (DNA) sequences from human chromosomes and chromosomes of other organisms are enabling a detailed look at the structure and …See details»